Symbol | Exchange | Currency |
|---|
Investing.com - Dice Molecules Holdings LLC (NASDAQ: DICE) reported first quarter EPS of $-0.54, $0.06 better than the analyst estimate of $-0.60. Revenue for the quarter came in...
DICE Therapeutics (DICE) has filed mixed shelf of: Common Stock, Preferred Stock, Debt Securities, Warrants, Subscription Rights and Units
DICE Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing oral therapeutics against well-validated targets in immunology. The Company's platform, DELSCAPE, is designed to discover selective oral small molecules with the potential to modulate protein-protein interactions (PPIs). The Company's therapeutic candidate, DC-806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in a variety of immunology indications. The Company is also developing oral therapeutic candidates targeting a4B7 integrin for the treatment of inflammatory bowel disease (IBD) and evaluating oral therapeutic candidates targeting aVB1/aVB6 integrin for the treatment of fibrosis.
| Average | 61.30 (+104.13% Upside) |
| High | 77.00 |
| Low | 38.00 |
| Price | 30.03 |
| No. of Analysts | 10 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Summary | Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 90.77 | 91.34 | 89.60 | +2.18 | +2.46% | 14.26M | NYSE | |||
| 31.45 | 31.51 | 31.15 | +0.28 | +0.90% | 7.14M | NASDAQ | |||
| 5.00 | 5.00 | 5.00 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 9.82 | 9.86 | 9.23 | +0.71 | +7.79% | 109.41K | NASDAQ | |||
| 133.45 | 135.45 | 132.17 | +2.66 | +2.03% | 2.63M | NASDAQ | |||
| 3.11 | 3.21 | 3.06 | -0.04 | -1.27% | 33.99K | NYSE | |||
| 125.23 | 126.75 | 124.35 | +0.86 | +0.69% | 19.22M | NASDAQ | |||
| 7.52 | 7.72 | 7.38 | +0.19 | +2.59% | 7.06M | NYSE | |||
| 16.65 | 16.65 | 16.65 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 47.39 | 47.44 | 45.82 | +1.62 | +3.54% | 367.13K | NYSE | |||
| 8.39 | 8.39 | 8.10 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 0.0001 | 0.0001 | 0.0001 | 0.00 | 0.00% | 275.00 | OTC Markets | |||
| 69.54 | 72.00 | 69.36 | +0.45 | +0.65% | 9.28M | NASDAQ | |||
| 3.07 | 3.29 | 3.00 | -0.120 | -3.76% | 3.93M | NASDAQ | |||
| 15.78 | 16.16 | 15.68 | +0.27 | +1.74% | 15.57M | NYSE |